POS8-0025
The impact of topology and chain length of polyvinylpyrrolidone macromolecules on the crystallization of naproxen
Topic
S8. Frontiers of Functional Polymers in Biology and Medicine
When and Where
Oct 1, 2026
08:30 - 09:30
Room 301 (Grand Ballroom)
Session Chairs
Jinkee HONG
Ki Su KIM
Presenter(s)
Ewa Ozimina Kaminska (Department of Pharmacognosy and Phytochemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Jagiellonska 4, 41-200 Sosnowiec, Poland)
Co-Author(s)
Abstract
This study explores the application of self-synthesized polyvinylpyrrolidone (PVP) homopolymers with diverse architectures as inhibitory matrices for the crystallization of naproxen (NAP), a poor glass-forming compound. Amorphous binary mixtures composed of NAP and (i) linear PVP (linPVP38k), (ii) three-arm star-shaped PVP (starPVP), (iii) linear PVP matching the molecular mass (Mn) of one star arm (linPVP14k), and (iv) commercial PVP K30, were examined. Using differential scanning calorimetry (DSC), X-ray diffraction (XRD), infrared spectroscopy (IR), and molecular dynamics (MD) simulations, we investigated the impact of polymer topology, chain length, and dispersity (Ð) on NAP crystallization kinetics and intermolecular interactions in NAP-PVP systems. Isothermal DSC studies revealed that linPVP38k with a higher Mn (~40,000) and low Ð is the most effective stabilizer, surpassing both the star-shaped architecture and the commercial reference. Interestingly, near the Tg, NAP crystallization proceeds at a similar rate for the mixtures with starPVP and linPVP14k (matching the Mn of one star arm). XRD investigations showed that, regardless of the polymer topology or Mn, NAP crystallizes into the same polymorphic form. IR and MD simulations demonstrated that the greatest long-term stability (up to four months) of the 60:40 w/w NAP-PVP systems, confirmed by XRD, is mainly due to H-bonds between NAP and PVP molecules. The high polymer content prevents the self-association of NAP molecules, thus significantly affecting crystallization kinetics. Moreover, MD analysis indicated the greatest homogeneity in the NAP-linPVP38k mixture, explaining the effective crystallization inhibition by the polymer with an Mn similar to PVP K30 but with relatively uniform chain lengths (low Ð). These findings are of particular importance for the design of new pharmaceutical formulations containing polymers with well-defined macromolecular parameters and architectures.













